ANS/ Parasympathetic Division


  • Functional Dualism (Yin and Yang Relationship):

    • The sympathetic and parasympathetic divisions of the autonomic nervous system (ANS) act as functional opposites across most physiological systems.

    • Heart Rate: Sympathetic stimulation increases heart rate; parasympathetic stimulation decreases heart rate.

    • Salivation: Sympathetic stimulation decreases salivation (producing viscous, sparse saliva); parasympathetic stimulation increases salivation (producing watery, abundant saliva).

    • Airway Diameter: Sympathetic stimulation causes bronchodilation; parasympathetic stimulation causes bronchoconstriction.

    • Pupil Diameter: Sympathetic stimulation causes pupil dilation (mydriasis); parasympathetic stimulation causes pupil constriction (miosis).

  • Anatomical Outflow and Exit Sites:

    • Sympathetic Division (Thoracolumbar Outflow): Preganglionic fibers exit the central nervous system (CNS) between spinal cord segments T1T1 and L2L2.

    • Parasympathetic Division (Craniosacral Outflow): Preganglionic fibers exit the CNS above and below the thoracolumbar region.

      • Cranial Exit Sites: Cranial Nerves IIIIII, VIIVII, IXIX, and XX.

      • Sacral Exit Sites: Spinal nerves between S2S2 and S4S4.

  • Fiber Lengths and Ganglia Distribution:

    • Sympathetic Structural Pattern:

      • Short preganglionic fibers.

      • Long postganglionic fibers.

      • Ganglia Locations: Paravertebral ganglia (sympathetic chain ganglia along the vertebral column), prevertebral ganglia (collateral ganglia anterior to the vertebral column), or specialized neuroendocrine cells within the adrenal medulla.

    • Parasympathetic Structural Pattern:

      • Long preganglionic fibers.

      • Short postganglionic fibers.

      • Ganglia Locations: Located close to or embedded directly within the walls of the target organ/effector.

      • Terminology: These ganglia are designated as terminal ganglia or intramural ganglia (intra meaning "within", mural meaning "wall").

Cranial Nerves and the Vagus Nerve (CN X)

  • Parasympathetic Cranial Nerves:

    • Cranial Nerve IIIIII: Oculomotor nerve (innervates intrinsic eye muscles for pupil constriction and lens accommodation).

    • Cranial Nerve VIIVII: Facial nerve (innervates lacrimal, submandibular, and sublingual glands).

    • Cranial Nerve IXIX: Glossopharyngeal nerve (innervates the parotid salivary gland).

    • Cranial Nerve XX: Vagus nerve.

  • Vagus Nerve (CNXCN\,X) Scope and Significance:

    • Etymology: The word vagus translates to "wanderer," named because the nerve exits the base of the brainstem and travels extensively throughout the thoracic and abdominopelvic cavities.

    • Anatomical Distribution: Unlike Cranial Nerves IIIIII, VIIVII, and IXIX (which exclusively target structures in the head and neck), CNXCN\,X innervates visceral organs in the chest and abdomen, including the heart, lungs, stomach, liver, pancreas, intestines, and kidneys.

    • Quantitative Contribution: The two vagus nerves account for approximately 75%75\% of all parasympathetic outflow in the human body.

    • Clinical Importance: Loss or bilateral transection of the vagus nerves is fatal without medical life-support intervention due to the total loss of parasympathetic visceral regulation.

Neurotransmitters and Receptor Mechanisms in the ANS

  • Exclusive Autonomic Neurotransmitters:

    • The autonomic nervous system utilizes only two primary neurotransmitters across all standard synapses:

      1. Acetylcholine (AChACh)

      2. Norepinephrine (NENE / Noradrenaline)

    • Note: Epinephrine (EpiEpi) acts primarily as a circulating hormone released by the adrenal medulla rather than a direct sympathetic neurotransmitter. Other chemicals like dopamine or muscarine are not standard ANS neurotransmitters.

  • Determinant of Physiological Effect:

    • The ultimate response of a target organ (excitation or inhibition) is dictated by the specific receptor subtype expressed on the postsynaptic membrane, not by the chemical identity of the neurotransmitter itself.

  • Universal ANS Pre-to-Post Synapse Rule:

    • At all preganglionic-to-postganglionic synapses (in both sympathetic and parasympathetic divisions), the preganglionic neuron releases Acetylcholine (AChACh).

    • The postsynaptic receptor on the postganglionic neuron dendrites and cell bodies is always the Nicotinic Acetylcholine Receptor (nAChRnAChR).

    • This arrangement ensures rapid, 100%100\% excitatory transmission to activate the secondary neuron.

Receptor Subtypes: Nicotinic, Muscarinic, and Adrenergic

  • Nicotinic Acetylcholine Receptors (nAChRnAChR):

    • Mechanism: Ionotropic receptors. Upon AChACh binding directly to the receptor, an integral ion channel opens, allowing influx of sodium ions (Na+Na^+) down their electrochemical gradient.

    • Effect: Rapid membrane depolarization; always 100%100\% excitatory.

    • Anatomical Locations:

      • All postganglionic cell bodies and dendrites in both sympathetic and parasympathetic ganglia.

      • Skeletal muscle endplates at the neuromuscular junction (NMJNMJ).

      • Hormone-secreting cells of the adrenal medulla.

    • Exogenous Agonist: Nicotine (derived from tobacco). Nicotine binds and activates nAChRnAChR, mimicking AChACh. Chronic nicotine introduction alters baseline central nervous system neuronal firing set-points, causing severe withdrawal and cravings when nicotine levels drop.

  • Muscarinic Acetylcholine Receptors (mAChRmAChR):

    • Mechanism: Metabotropic receptors (G-protein coupled receptors). Ligand binding initiates intracellular signal transduction cascades via G-proteins, modifying second messengers and cellular metabolism indirectly.

    • Effect: Excitatory or inhibitory depending on the target tissue's specific G-protein coupling and downstream effectors.

    • Anatomical Locations:

      • All parasympathetic postganglionic-to-target synapses (cardiac muscle, smooth muscle, glands).

      • Sympathetic postganglionic-to-target synapses innervating sweat glands, piloerector muscles, and blood vessels of the skin.

    • Exogenous Agonist: Muscarine (a toxin found in certain poisonous mushrooms). Ingestion of muscarine hyper-activates mAChRmAChR, producing extreme parasympathetic overstimulation: profuse salivation, lacrimation, severe bronchoconstriction, extreme bradycardia, and potential mortality.

    • Toxicological Application: Nerve agents (nerve gas) inhibit acetylcholinesterase, leading to massive excess AChACh at mAChRmAChR sites, causing death via airway constriction and fluid asphyxiation.

  • Adrenergic Receptors (Alpha and Beta):

    • Mechanism: Both Alpha (α\alpha) and Beta (β\beta) receptors are metabotropic receptors that bind norepinephrine released from sympathetic postganglionic neurons or epinephrine/norepinephrine circulating as hormones.

    • Alpha (α\alpha) Adrenergic Receptors:

      • Generally excitatory to target tissues.

      • Example: Activation of α1\alpha_1 receptors on vascular smooth muscle in abdominal viscera causes muscle contraction and vasoconstriction, diverting blood away from digestive organs.

    • Beta (β\beta) Adrenergic Receptors:

      • Generally inhibitory to smooth muscle, but with vital excitatory exceptions.

      • Inhibitory Example: Activation of β2\beta_2 receptors on bronchial smooth muscle causes muscle relaxation and bronchodilation.

      • Excitatory Exception (Heart): Cardiac muscle expresses β1\beta_1 adrenergic receptors. Activation of β1\beta_1 receptors in the heart is excitatory, increasing heart rate (chronotropy) and force of contraction (inotropy).

  • Pharmacological Applications:

    • Beta-Blockers: Drugs that antagonize β1\beta_1 receptors on cardiac tissue. By blocking \NE and \Epi binding, these medications reduce heart rate and lower blood pressure in hypertensive patients.

      • Non-selective Beta-Blockers: Block β1\beta_1, β2\beta_2, and β3\beta_3 receptors broadly, causing widespread systemic side effects (e.g., unintended bronchoconstriction via β2\beta_2 blockade).

      • Selective Beta-Blockers: Target β1\beta_1 receptors specifically, minimizing off-target adverse effects but requiring complex molecular synthesis.

    • EpiPens vs. NorEpiPens: β2\beta_2 receptors on airway smooth muscle exhibit a significantly higher binding affinity for epinephrine (EpiEpi) than for norepinephrine (NENE). Higher affinity ensures stronger, longer-lasting receptor engagement and rapid bronchodilation during severe allergic reactions or asthma attacks, rendering Epinephrine the agent of choice in emergency auto-injectors.

Physiological System Characteristics and Autonomic Tone

  • Distribution and Duration Comparison:

    • Systemic Distribution: The sympathetic division is far more widely distributed throughout the body than the parasympathetic division. Sympathetic fibers innervate every tissue, including the skin, sweat glands, arrector pili muscles, and peripheral blood vessels, whereas parasympathetic innervation is restricted to visceral organs and head/neck structures.

    • Duration of Response: Sympathetic effects last substantially longer than parasympathetic effects.

      • Parasympathetic Synapses: Synaptic AChACh is rapidly hydrolyzed and inactivated by the enzyme acetylcholinesterase (AChEAChE) directly within the synaptic cleft.

      • Sympathetic Synapses: NENE lacks a high-concentration degradation enzyme in the synaptic cleft, clearing more slowly via reuptake or systemic diffusion, resulting in prolonged downstream activity.

  • Glandular Regulation Mechanisms:

    • Autonomic control over glands occurs through two mechanisms:

      1. Direct stimulation of secretory acinar cells.

      2. Indirect regulation via vasoconstriction or vasodilation of blood vessels supplying the gland. Adjusting blood flow alters raw nutrient and fluid availability, controlling total secretory volume.

  • Concept of Autonomic Tone:

    • Autonomic Tone: The continuous baseline firing rate of autonomic nerve fibers, maintaining ongoing low-level activity in target organs regardless of conscious exertion.

    • Vagal Tone in the Heart:

      • The intrinsic cardiac pacemaker (SA node) depolarizes spontaneously at approximately 100beats/min100\,\text{beats/min}.

      • Continuous parasympathetic firing via the vagus nerve (CNXCN\,X) releases AChACh onto cardiac mAChRmAChR, tonicly depressing heart rate down to a normal resting baseline of approximately 70beats/min70\,\text{beats/min}.

    • Sympathetic Tone in Blood Vessels:

      • Vascular smooth muscle lacks parasympathetic innervation.

      • Continuous baseline action potential firing from sympathetic postganglionic fibers maintains partial smooth muscle contraction, establishing baseline blood pressure and vascular resistance.

  • Single-Division Control via Action Potential Frequency:

    • For single-innervated structures like blood vessels, physiological diameter is controlled strictly by altering the frequency of sympathetic action potentials:

      • Increased Firing Rate: Heightened NENE release causes increased smooth muscle contraction, leading to vasoconstriction.

      • Decreased Firing Rate: Diminished NENE release allows smooth muscle relaxation, leading to passive vasodilation.

    • Because baseline sympathetic tone maintains a non-zero baseline frequency, the system can dial tissue activity up or down using only one neural pathway.

  • Dual Innervation and Synergistic Cooperation:

    • Antagonistic Dual Innervation: Most visceral organs (e.g., lungs, heart, digestive tract) receive dual innervation from both divisions, where one division directly opposes the action of the other.

    • Cooperative Interactions (Reproductive System): In reproductive function, the two divisions act sequentially and synergistically rather than antagonistically:

      1. Parasympathetic Division: Dominates initial arousal, inducing vasodilation to produce genital erection.

      2. Sympathetic Division: Dominates secondary activation, driving ejaculation in males / systemic smooth muscle contraction and physiological resolution.